Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Bornstein

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Biology of Reproduction|October 17, 2003
Thrombospondin 2 deficiency in pregnant mice results in premature softening of the uterine cervixRobert Kokenyesi, Lucas C Armstrong, Azin Agah, et al.
Molecular and Cellular Biology|June 21, 2005
Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femoral headKurt D Hankenson, Sheriar G Hormuzdi, Jeffrey A Meganck, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 5, 2004
Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesisAzin Agah, Themis R Kyriakides, Nikole Letrondo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 17, 2010
Expression in SPARC-null mice of collagen type I lacking the globular domain of the α1(I) N-propeptide results in abdominal hernias and loss of dermal collagenLauren Card, Nikki Henderson, Yuhua Zhang, et al.
Journal of Cellular Physiology|December 13, 2006
Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1)James Greenaway, Jack Lawler, Roger Moorehead, et al.
The Journal of Biological Chemistry|December 21, 2006
Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cellsPriya Raman, Irene Krukovets, Tina E Marinic, et al.
Molecular Biology of the Cell|November 23, 2007
Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cellsAnush Oganesian, Lucas C Armstrong, Mary M Migliorini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Interactions between CD47 and thrombospondin reduce inflammationLaurence Lamy, Arnaud Foussat, Eric J Brown, et al.
The Journal of Biological Chemistry|May 25, 2007
SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblastsTyler J Rentz, Felicitta Poobalarahi, Paul Bornstein, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|March 3, 2011
Dynamic reciprocity in the wound microenvironmentGregory S Schultz, Jeffrey M Davidson, Robert S Kirsner, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Biology of Reproduction|October 17, 2003
Thrombospondin 2 deficiency in pregnant mice results in premature softening of the uterine cervixRobert Kokenyesi, Lucas C Armstrong, Azin Agah, et al.
Molecular and Cellular Biology|June 21, 2005
Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femoral headKurt D Hankenson, Sheriar G Hormuzdi, Jeffrey A Meganck, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 5, 2004
Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesisAzin Agah, Themis R Kyriakides, Nikole Letrondo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 17, 2010
Expression in SPARC-null mice of collagen type I lacking the globular domain of the α1(I) N-propeptide results in abdominal hernias and loss of dermal collagenLauren Card, Nikki Henderson, Yuhua Zhang, et al.
Journal of Cellular Physiology|December 13, 2006
Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1)James Greenaway, Jack Lawler, Roger Moorehead, et al.
The Journal of Biological Chemistry|December 21, 2006
Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cellsPriya Raman, Irene Krukovets, Tina E Marinic, et al.
Molecular Biology of the Cell|November 23, 2007
Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cellsAnush Oganesian, Lucas C Armstrong, Mary M Migliorini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Interactions between CD47 and thrombospondin reduce inflammationLaurence Lamy, Arnaud Foussat, Eric J Brown, et al.
The Journal of Biological Chemistry|May 25, 2007
SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblastsTyler J Rentz, Felicitta Poobalarahi, Paul Bornstein, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|March 3, 2011
Dynamic reciprocity in the wound microenvironmentGregory S Schultz, Jeffrey M Davidson, Robert S Kirsner, et al.
Pageof 6